Personalized Cancer Treatment Breakthrough: mRNA Vaccines and CAR-T Cell Therapy

1. Moving from Organ Taxonomy to Molecular Precision

Historically classified merely by anatomical site (lung, breast, colon), cancer is now understood as unique genomic mutations. Biotechnology pioneers are utilizing mRNA platforms to formulate custom therapeutic vaccines for individual patients.

2. Mechanism of Neoantigen mRNA Vaccines

By sequencing tumor tissue against healthy germline DNA, algorithms isolate specific tumor neoantigens, formulating an individualized mRNA vaccine within weeks that programs cytotoxic T-cells to eradicate microscopic tumor residues.

3. Living Drugs: CAR-T Cell Therapy in Clinical Practice

Autologous CAR-T cell therapies represent living treatments, genetically engineered to destroy hematological malignancies. Emerging local manufacturing initiatives in Turkey aim to democratize access to therapies traditionally carrying six-figure treatment costs.